Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
1 |
Baccarani M et al. |
Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study.
|
2 |
Grönroos P et al. |
Normal leukocyte count and C-reactive protein value do not effectively exclude acute appendicitis in children.
|
3 |
Hiekkanen H et al. |
Association of injury severity, MRI-results and ApoE genotype with 1-year outcome in mainly mild TBI: A preliminary study.
|
4 |
Kaitosaari T et al. |
Tracking and determinants of LDL particle size in healthy children from 7 to 11 years of age: the STRIP Study.
|
5 |
Kallio K et al. |
Decreased aortic elasticity in healthy 11-year-old children exposed to tobacco smoke .
|
6 |
Kankuri-Tammilehto M. |
Prognostic Markers and Prolonged Interferon-alfa Therapy In Renal Cell Carcinoma.
|
7 |
Karvonen J et al. |
The diameter of common bile duct does not predict the cause of extrahepatic cholestasis.
|
8 |
Kelo E et al. |
Depletion of L-asparagine supply and apoptosis of leukemia cells induced by human glycosylasparaginase.
|
9 |
Korja M et al. |
Absence of polysialylated NCAM is an unfavorable prognostic phenotype for advanced stage neuroblastoma.
|
10 |
Koskenvuo JW et al. |
Echocardiography in Fabry disease: diagnostic value of endocardial border binary appearance.
|
11 |
Kurkijärvi R et al. |
StaRRsed AutoCompact -laskoanalysaattorin koestus.
|
12 |
Leino A, Koivula MK. |
Stability of chemical and immunochemical analytes in uncentrifuged plasma samples.
|
13 |
Lähteenmäki P et al. |
Severe congenital neutropenia and pegfilgrastim.
|
14 |
Nyrhinen T et al. |
Are patient rights to information and self-determination in diagnostic genetic testing upheld? A comparison of patients' and providers' perceptions.
|
15 |
Putkonen M et al. |
Single-dose pegfilgrastim is comparable to daily filgrastim in moblilizing peripheral blood stem cells: a case-matched study in patients with lymphoproliferative malignancies.
|